‹ Screener

10x Genomics, Inc.

TXG · Laboratory Analytical Instruments · 122.3M shares · +32%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$167M (gross $80K, SBC $167M)

Reference price $33.29 · est. market cap ~$4.1B — last insider sale, 2026-06-22 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

C60

Genomics-tools company (Chromium/Xenium) — near breakeven with positive free cash flow and elite gross margin.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $173M2025-09-30 · $149M2025-12-31 · $166M2026-03-31 · $151M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
69.1%
Operating margin
-9.5%
Net margin
-6.8%
Return on equity
-5.5%
Return on assets
-4.2%
Revenue growth (QoQ)
-9.1%
Current ratio
4.5×
Free cash flow
$130M
EBITDA
-$25M
Tangible book value
$729M
Stock comp / revenue
17.0%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-22Saxonov SergeSell10.0K$34.28
2026-06-22Saxonov SergeSell9.8K$35.32
2026-06-22Saxonov SergeSell8.5K$33.29
2026-06-22Saxonov SergeSell1.7K$36.16
2026-06-16SULIMAN SHEHNAAZSell5.4K$32.59
2026-06-16SULIMAN SHEHNAAZSell364$33.27
2026-06-04Teichmann Sarah A.Grant8.8K
2026-06-04SULIMAN SHEHNAAZGrant8.8K
2026-06-04STUELPNAGEL JOHN RGrant8.8K
2026-06-04Popovits Kimberly JGrant8.8K
2026-06-04MATEO ALANGrant8.8K
2026-06-04Kosaraju SridharGrant8.8K
2026-05-26Saxonov SergeSell11K$24.71
2026-05-22Hindson Benjamin J.Sell12K$24.44
2026-05-22Saxonov SergeSell18K$24.44
2026-05-22Taich AdamSell15K$24.44
2026-04-14Saxonov SergeSell5.0K$24.56
2026-03-24Saxonov SergeSell5.0K$19.52
2026-03-23Saxonov SergeSell10K$19.13
2026-03-03Saxonov SergeGift2.8K
2026-03-02Saxonov SergeSell14K$22.67
2026-03-02Saxonov SergeSell1.9K$23.18
2026-02-26Saxonov SergeGrant158K
2026-02-26Hindson Benjamin J.Grant89K
2026-02-26Taich AdamGrant107K
2026-02-25Teichmann Sarah A.Sell7.6K$19.41
2026-02-23Hindson Benjamin J.Sell7.8K$18.58
2026-02-23Saxonov SergeSell9.6K$18.58
2026-02-23Taich AdamSell9.0K$18.58
2026-01-05Saxonov SergeOption exercise50K$1.20
2025-11-24Hindson Benjamin J.Sell8.3K$19.00
2025-11-24Saxonov SergeSell13K$19.00
2025-11-24Taich AdamSell12K$19.00
2025-09-12Saxonov SergeGift900
2025-08-22Saxonov SergeSell9.3K$13.79
2025-08-22Taich AdamSell22K$13.79
2025-08-22Hindson Benjamin J.Sell7.5K$13.79
2025-06-09Saxonov SergeGift1.0K
2025-06-03MATEO ALANGrant15K
2025-06-03Teichmann Sarah A.Grant15K
2025-06-03SULIMAN SHEHNAAZGrant15K
2025-06-03STUELPNAGEL JOHN RGrant15K
2025-06-03Popovits Kimberly JGrant15K
2025-06-03Kosaraju SridharGrant15K
2025-05-29Saxonov SergeGift3.0K
2025-05-22Saxonov SergeSell9.3K$8.30
2025-05-22Hindson Benjamin J.Sell7.5K$8.30
2025-05-22Taich AdamSell4.0K$8.30
2025-03-17Taich AdamGrant134K
2025-03-17Saxonov SergeGrant171K
2025-03-17Hindson Benjamin J.Grant121K
2025-03-04Saxonov SergeOption exercise50K$1.20
2025-02-28Saxonov SergeSell7.9K$10.63
2025-02-24Hindson Benjamin J.Sell4.6K$11.07
2025-02-24Saxonov SergeSell5.1K$11.07
2025-02-21MATEO ALANBuy40K$11.14

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-08Shareholder votefiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-02-12ResultsExhibitsfiling ↗
2026-01-12Resultsfiling ↗
2025-11-14Exec/director changefiling ↗
2025-11-06ResultsExhibitsfiling ↗
2025-08-07ResultsExhibitsfiling ↗
2025-06-05Shareholder votefiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-082026-06-040001628280-26-041651 ↗
10-Q2026-05-082026-03-310001628280-26-032388 ↗
8-K2026-05-072026-05-070001628280-26-032073 ↗
10-K2026-02-132025-12-310001628280-26-007822 ↗
8-K2026-02-122026-02-120001628280-26-007673 ↗
8-K2026-01-122026-01-110001628280-26-001808 ↗
8-K2025-11-142025-11-120001628280-25-052154 ↗
10-Q2025-11-072025-09-300001628280-25-050332 ↗
8-K2025-11-062025-11-060001770787-25-000058 ↗
10-Q2025-08-082025-06-300001770787-25-000051 ↗
8-K2025-08-072025-08-070001770787-25-000048 ↗
8-K2025-06-052025-06-030001770787-25-000040 ↗